{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:38:27Z","timestamp":1792319907085,"version":"4.4.0"},"reference-count":34,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1882,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidem. Drug Safe."],"DOI":"10.1002\/pds.1978","type":"journal-article","created":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T15:01:53Z","timestamp":1278514913000},"page":"792-802","source":"Crossref","is-referenced-by-count":61,"title":["Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study"],"prefix":"10.1002","volume":"19","author":[{"given":"Sascha","family":"Dublin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rod L.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel S.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,7,7]]},"reference":[{"key":"10.1002\/pds.1978-BIB1|cit1","first-page":"2128","article-title":"The burden of gastrointestinal and liver diseases, 2006","volume":"101","author":"Shaheen","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1002\/pds.1978-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1046\/j.1365-2036.2003.01600.x","article-title":"Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey","volume":"17","author":"Parente","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1002\/pds.1978-BIB3|cit3","first-page":"1203","article-title":"Long-term use of acid suppression started inappropriately during hospitalization","volume":"21","author":"Zink","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1002\/pds.1978-BIB4|cit4","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1111\/j.1572-0241.2000.02680.x","article-title":"Overuse of acid-suppressive therapy in hospitalized patients","volume":"95","author":"Nardino","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1002\/pds.1978-BIB5|cit5","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.317.7156.452","article-title":"Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database","volume":"317","author":"Bashford","year":"1998","journal-title":"BMJ"},{"key":"10.1002\/pds.1978-BIB6|cit6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.amjopharm.2008.12.001","article-title":"Appropriate proton pump inhibitor use among older adults: a retrospective chart review","volume":"6","author":"George","year":"2008","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1002\/pds.1978-BIB7|cit7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jamda.2007.07.001","article-title":"Use of proton pump inhibitors and other acid suppressive medications in newly admitted nursing facility patients","volume":"8","author":"Glew","year":"2007","journal-title":"J Am Med Dir Assoc"},{"key":"10.1002\/pds.1978-BIB8|cit8","first-page":"2200","article-title":"Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients","volume":"101","author":"Heidelbaugh","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1002\/pds.1978-BIB9|cit9","first-page":"757","article-title":"Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial","volume":"51","author":"Kantorova","year":"2004","journal-title":"Hepato-Gastroenterology"},{"key":"10.1002\/pds.1978-BIB10|cit10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.7326\/0003-4819-120-8-199404150-00005","article-title":"Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer: a randomized controlled trial","volume":"120","author":"Prod'hom","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1002\/pds.1978-BIB11|cit11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1053\/bega.2001.0191","article-title":"Occurrence and significance of gastric colonization during acid-inhibitory therapy","volume":"15","author":"Williams","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1002\/pds.1978-BIB12|cit12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1155\/2008\/821385","article-title":"Association between proton pump inhibitors and respiratory infections: a systematic review and meta-analysis of clinical trials","volume":"22","author":"Sultan","year":"2008","journal-title":"Can J Gastroenterol"},{"key":"10.1002\/pds.1978-BIB13|cit13","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2165\/00002018-200831070-00008","article-title":"Occurrence of community-acquired respiratory tract infection in patients receiving esomeprazole: retrospective analysis of adverse events in 31 clinical trials","volume":"31","author":"Estborn","year":"2008","journal-title":"Drug Saf"},{"key":"10.1002\/pds.1978-BIB14|cit14","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/archinte.167.9.950","article-title":"Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study","volume":"167","author":"Gulmez","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1002\/pds.1978-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.2009.722","article-title":"Acid-suppressive medication use and the risk for hospital-acquired pneumonia","volume":"301","author":"Herzig","year":"2009","journal-title":"JAMA"},{"key":"10.1002\/pds.1978-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1001\/jama.292.16.1955","article-title":"Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs","volume":"292","author":"Laheij","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/pds.1978-BIB17|cit17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/pds.1715","article-title":"Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study","volume":"18","author":"Myles","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1002\/pds.1978-BIB18|cit18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7326\/0003-4819-149-6-200809160-00005","article-title":"Proton-pump inhibitor use and the risk for community-acquired pneumonia","volume":"149","author":"Sarkar","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1002\/pds.1978-BIB19|cit19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jclinepi.2004.11.020","article-title":"Preferred provider organization claims showed high predictive value but missed substantial proportion of adults with high-risk conditions","volume":"58","author":"Ahmed","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"10.1002\/pds.1978-BIB20|cit20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00005650-200208000-00007","article-title":"Validity of information on comorbidity derived from ICD-9-CCM administrative data","volume":"40","author":"Quan","year":"2002","journal-title":"Med Care"},{"key":"10.1002\/pds.1978-BIB21|cit21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(08)61160-5","article-title":"Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study","volume":"372","author":"Jackson","year":"2008","journal-title":"Lancet"},{"key":"10.1002\/pds.1978-BIB22|cit22","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1016\/j.vaccine.2008.07.016","article-title":"Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults","volume":"26","author":"Nelson","year":"2008","journal-title":"Vaccine"},{"key":"10.1002\/pds.1978-BIB23|cit23","first-page":"234","volume-title":"Pharmacoepidemiology","author":"Saunders","year":"2005"},{"key":"10.1002\/pds.1978-BIB24|cit24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/pds.1119","article-title":"Reliability of Group Health Cooperative automated pharmacy data by drug benefit status","volume":"14","author":"Boudreau","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1002\/pds.1978-BIB25|cit25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1002\/pds.1978-BIB26|cit26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.38875.675486.55","article-title":"A meta-analysis of the association between adherence to drug therapy and mortality","volume":"333","author":"Simpson","year":"2006","journal-title":"BMJ"},{"key":"10.1002\/pds.1978-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM198010303031804","article-title":"Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project","volume":"303","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1002\/pds.1978-BIB28|cit28","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/aje\/kwm070","article-title":"Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect","volume":"166","author":"Brookhart","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1002\/pds.1978-BIB29|cit29","first-page":"1839","article-title":"Specificity and sensitivity of claims-based algorithms for identifying members of Medicare+Choice health plans that have chronic medical conditions","volume":"39","author":"Rector","year":"2004","journal-title":"Health Serv Res"},{"key":"10.1002\/pds.1978-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/00003246-200205000-00026","article-title":"Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity","volume":"30","author":"Zedtwitz-Liebenstein","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1002\/pds.1978-BIB31|cit31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10620-007-9869-2","article-title":"Omeprazole inhibits natural killer cell functions","volume":"53","author":"Alkim","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1002\/pds.1978-BIB32|cit32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1213\/00000539-199907000-00040","article-title":"The effects of cimetidine, ranitidine, and famotidine on human neutrophil functions","volume":"89","author":"Mikawa","year":"1999","journal-title":"Anesth Analg"},{"key":"10.1002\/pds.1978-BIB33|cit33","first-page":"457","article-title":"Design and analysis of two-phase studies with binary outcomes applied to Wilms tumor prognosis","volume":"48","author":"Breslow","year":"1999","journal-title":"Appl Stat"},{"key":"10.1002\/pds.1978-BIB34|cit34","first-page":"27","article-title":"Statins and the risk of lung, breast, and colorectal cancer in the elderly","volume":"115","author":"Setoguchi","year":"2007","journal-title":"Circulation"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.1978","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pds.1978","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T01:28:52Z","timestamp":1635643732000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.1978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,7]]},"references-count":34,"journal-issue":{"issue":"8"},"URL":"https:\/\/doi.org\/10.1002\/pds.1978","relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,7]]}}}